Neuralink, Elon Musk’s brain-computer interface (BCI) company, has received the FDA's “breakthrough device” designation for its innovative 'Blindsight' implant.
Synchron, a competitor to Neuralink, has announced one of its patients with ALS is now able to control devices using only his mind with its brain chip implant.
Neuralink has implanted its experimental N1 brain-computer interface (BCI) within a second patient, with Elon Musk, the company's CEO, saying the procedure is “working very well.”